# Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)

> **NCT01650168** · — · COMPLETED · sponsor: **Center for Epidemiology and Health Research, Germany** · enrollment: 101498 (actual)

## Conditions studied

- Contraception

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01650168
- **Lead sponsor:** Center for Epidemiology and Health Research, Germany
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 101498 (ACTUAL)
- **Last updated:** 2021-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01650168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01650168, "Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01650168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*